Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT01294007
Other study ID # PRO-000061
Secondary ID
Status Terminated
Phase N/A
First received
Last updated
Start date February 2011
Est. completion date November 2013

Study information

Verified date September 2022
Source Alphatec Spine, Inc.
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to evaluate the rate and quality of fusion of PureGen Osteoprogenitor Cell Allograft, compared to autograft bone in instrumented posterolateral fusion (PLF) procedures.


Description:

This is a prospective, multi-center, observational, self-control study assessing screened and consented subjects undergoing instrumented posterolateral fusion for degenerative disc disease (DDD) at 1 to 2 contiguous levels between L1 and S1. Patients diagnosed with DDD will be screened for enrollment based on inclusion and exclusion criteria outlined in this protocol. Subjects who are successfully screened and sign an informed consent will undergo PLF surgery utilizing PureGen, Alphagraft ProFuse Demineralized Bone Scaffold (DBS), and ZODIAC, Illico, or Xenon Fixation system (pedicle screw and rod fixation system) Subjects will be followed at 6 weeks, 3, 6, 12 and 24 month post-operative visits. Standard radiographs will be taken at these visits to evaluate fusion rate and quality. Oswestry Disability Index (ODI) and Visual Analog Scale (VAS) self-assessment questionnaires and neurological exams will be administered to measure pain and function scores. A computerized tomography (CT) scan will be taken at the 6-month to further assess rate and quality of fusion. A conditional 12 and 24 month post operative CT may also be taken. Procedure related and PureGen related adverse events will be monitored throughout the study.


Recruitment information / eligibility

Status Terminated
Enrollment 1
Est. completion date November 2013
Est. primary completion date November 2013
Accepts healthy volunteers No
Gender All
Age group 50 Years and older
Eligibility Inclusion Criteria: - Symptomatic lumbar degenerative disc disease in up to two contiguous levels between L1 and S1 - Subjects with back and/or leg pain indicated for posterior stabilization with or without decompression at any level and posterolateral fusion (PLF) - Unresponsive to conservative treatment for at least 6 months - Radiographic evidence of primary diagnosis Exclusion Criteria: - More than 2 levels requiring posterolateral fusion - Spondylolisthesis greater than Grade I - Prior failed fusion surgery at any lumbar level(s) - Systemic or local infection in the disc or cervical spine, past or present - Active systemic disease - Osteoporosis, osteomalacia, or other metabolic bone disease that would significantly inhibit bone healing - Use of other bone graft, Bone Morphogenetic Protein (BMP) or bone graft substitutes in addition to or in place of those products specified - BMI greater than 40 - Use of post operative Spinal Cord Stimulator (SCS) - Known or suspected history of alcohol and/or drug abuse - Involved in pending litigation or worker's compensation related to the spine - Pregnant or planning to become pregnant during the course of the study - Insulin-dependent diabetes mellitus - Life expectancy less than duration of study - Any significant psychological disturbance that could impair consent process or ability to complete self-assessment questionnaires - Undergoing chemotherapy or radiation treatment, or chronic use of oral or injected steroids or prolonged use of non-steroidal anti-inflammatory drugs. - Known history of hypersensitivity or anaphylactic reaction to dimethyl sulfoxide (DMSO)

Study Design


Intervention

Biological:
PureGen Osteoprogenitor Cell Allograft
PureGen Osteoprogenitor Cell Allograft with posterior transpedicular fixation.
Procedure:
Autograft bone
Iliac Crest and Local Autograft Bone

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Alphatec Spine, Inc.

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of Patients With Fusion Number of patients with fusion at the 6- and conditional 12- and 24-month visit 6, 12 and 24 month
See also
  Status Clinical Trial Phase
Completed NCT01198470 - TRIUMPH Lumbar Artificial Disc IDE: A Pilot Study N/A
Terminated NCT00744861 - Ultrasound as Adjunct Therapy for Increasing Fusion Success After Lumbar Surgery N/A
Completed NCT00949936 - Safety and Performance Study of the CAdiscTM-L Lumbar Spinal Disc Replacement Device For CE Marking N/A
Completed NCT03974711 - Rampart Duo Clinical (RaDical) Post-Market Study
Recruiting NCT01721889 - Radiostereometric Analysis of Spine Arthrodesis N/A
Terminated NCT02139527 - CARES Lumbar Artificial Disc Registry Phase 4
Terminated NCT00878579 - Percutaneous Dynamic Stabilization (PDS) System Versus Fusion for Treating Degenerative Disc Disease Phase 2
Terminated NCT01689922 - The Effectiveness of Anti-Gravity Treadmill Training N/A
Completed NCT01640977 - A Prospective Non-concurrent Controlled Evaluation of Open and MAS® PLIF N/A
Enrolling by invitation NCT02529566 - Human Autograft Mesenchymal Stem Cell Mediated Stabilization of The Degenerative Lumbar Spine N/A
Completed NCT02347410 - Spineology Clinical Outcomes Trial: An IDE Investigation N/A
Terminated NCT02070484 - Human Amniotic Tissue-derived Allograft, NuCel, in Posteriolateral Lumbar Fusions for Degenerative Disc Disease N/A
Terminated NCT01293981 - Radiographic and Clinical Outcomes of PureGen in Posterior Lumbar (PLIF) and Transforaminal Interbody Fusion (TLIF) N/A
Terminated NCT00640029 - Evaluation of the Prosthetic Disc Replacement N/A
Terminated NCT00456378 - Study of the Safety and Effectiveness of DIAMâ„¢ Spinal Stabilization System Versus Conservative Care N/A
Completed NCT03647501 - Lumbar Fusion With Nexxt Spine 3D-Printed Titanium Interbody Cages N/A
Active, not recruiting NCT02297256 - Prospective Study of Thoracolumbar Spinal Fusion Graft N/A
Recruiting NCT05516992 - Moderate - Severe Degenerative Disc Disease Evaluation of the Lumbar Spine Phase 3
Completed NCT01323387 - Lumbar Degenerative Disc Disease Treated With Anterior Tension Band System (ATB) With ALIF/FRA Spacer N/A